NEW! Subscribe to Medtech Pro and get one or all of our reports, plus much more.

Global Markets for Drug Delivery: Transdermal and Inhalation Drug Delivery Technologies

106 Pages | 44 Exhibits | Forecasts Through 2020
market-report-samples/GlobalMarketSegments2.jpg market-report-samples/GlobalMarketSegments3caps.jpg market-report-samples/GlobalMarketSegmentsCaps.jpg
Buy Now

Overview

A new report from LSI, "Global Markets for Drug Delivery: Transdermal and Inhalation Drug Delivery Technologies in 2015," explores the dynamic market for transdermal drug patches, iontophoresis devices, dry powder inhalers, metered dose inhalers, and nebulizers. The market, which was valued at $8.2 billion in 2014, is being driven by powerful regional and economic forces; key among these are the introduction and adoption of generic products, rising caseloads, the pursuit of new and expanded therapeutic indications, and the state of healthcare development in important national markets. This report-which provides detailed forecasts for product segments, clinical caseloads, and global regions-analyzes the impacts these factors will have through 2020, examines competitive market shares, and highlights the main forces driving and limiting growth in the global market.

Critical Issues Covered in this Report:
•    The competitive landscape for transdermal drug delivery and inhalation devices in the U.S. and international       markets;
•    Revenues for key components and devices; and
•    Key caseloads for transdermal drug applications.

Table of Contents

1. EXECUTIVE SUMMARY
 
1.1 The United States 
1.2 Europe 
1.3 Asia-Pacific and the Rest of the World 
1.4 Competitive Analysis 

Exhibit 1-1: Global Market Forecast for Transdermal and Inhalation Drug Delivery Technologies by Product Type, 2013-2020 
Exhibit 1-2: Global Market Forecast for Transdermal and Inhalation Drug Delivery Technologies by Region, 2013-2020 
Exhibit 1-3: U.S. Market Forecast for Transdermal and Inhalation Drug Delivery Technologies by Product Type, 2013-2020 
Exhibit 1-4: European Market Forecast for Transdermal and Inhalation Drug Delivery Technologies by Product Type, 2013-2020 
Exhibit 1-5: AP & ROW Market Forecast for Transdermal and Inhalation Drug Delivery Technologies by Product Type, 2013-2020 
Exhibit 1-6: Global Supplier Shares in 2013 and 2014 

2. TRANSDERMAL AND INHALATION TECHNOLOGIES
 
2.1 Transdermal Technologies 
2.1.1 Iontophoresis 
2.1.2 Patches 
2.1.3 Microneedles 
2.2 Inhalation Devices 
2.2.1 Dry Powder Inhalers 
2.2.2 Metered Dose Inhalers 
2.2.3 Nebulizers 
2.2.4 Products and Suppliers 

Exhibit 2-1: Overview of Transdermal and Inhalation Drug Delivery Technologies 
Exhibit 2-2: Transdermal Technologies by Type 
Exhibit 2-3: Transdermal Drug Delivery Technologies: Selected Products and Suppliers in 2015 
Exhibit 2-4: Inhalation Technologies by Type 
Exhibit 2-5: Inhalation Devices: Selected Products and Suppliers in 2015 

3. TRANSDERMAL AND INHALATION DRUG DELIVERY TECHNOLOGIES: GLOBAL MARKET ANALYSIS
 
3.1 Patient Volumes and Market Forecasts: Transdermal Drug Delivery Technologies by Region 
3.1.1 The United States 
3.1.1.1 Cardiovascular 
3.1.1.2 Hormone Replacement 
3.1.1.3 Neurological/Psychiatric 
3.1.1.4 Pain Management 
3.1.1.5 Pregnancy Prevention 
3.1.1.6 Smoking Cessation 
3.1.1.7 Urology 
3.1.1.8 Iontophoresis 
3.1.1.9 Supplier Shares 
3.1.2 Europe 
3.1.3 Asia-Pacific and the Rest of the World 
3.2 Patient Volumes and Market Forecasts: Inhalation Drug Delivery Technologies by Region 
3.2.1 The United States 
3.2.1.1 Competitive Analysis 
3.2.2 Europe 
3.2.3 Asia-Pacific and the Rest-of-the-World 
3.2.4 Competitive Analysis 

Exhibit 3-1: Global Market Forecast for Transdermal and Inhalation Drug Delivery Technologies by Region, 2013-2020 
Exhibit 3-2: Global Market Forecast for Transdermal and Inhalation Drug Delivery Technologies by Product Type, 2013-2020 
Exhibit 3-3: U.S. Market Forecast for Transdermal Drug Delivery Technologies: Iontophoresis and Transdermal Patches, 2013-2020 
Exhibit 3-4: Key Caseloads for Transdermal Patches in the U.S., 2013-2020 
Exhibit 3-5: U.S. Market Forecast for Transdermal Patches by Category, 2013-2020 
Exhibit 3-6: U.S. Market Forecast for Transdermal Patches by Application, 2013-2020 
Exhibit 3-7: U.S. Market Forecast for Iontophoresis Devices, 2013-2020 
Exhibit 3-8: U.S. Supplier Shares, Transdermal Drug Delivery Technologies,  2013 and 2014 
Exhibit 3-9: European Market Forecast for Transdermal Drug Delivery Technologies: Iontophoresis and Transdermal Patches, 2013-2020 
Exhibit 3-10: Key Caseloads for Transdermal Patches in Europe, 2013-2020 
Exhibit 3-11: European Market Forecast for Transdermal Patches by Category, 2013-2020 
Exhibit 3-12: European Market Forecast for Transdermal Patches by Application, 2013-2020 
Exhibit 3-13: European Market Forecast for Iontophoresis Devices, 2013-2020 
Exhibit 3-14: AP & ROW Market Forecast for Transdermal Drug Delivery Technologies: Iontophoresis and Transdermal Patches, 2013-2020 
Exhibit 3-15: Key Caseloads for Transdermal Patches in AP & ROW Countries, 2013-2020 
Exhibit 3-16: AP & ROW Market Forecast for Transdermal Patches by Category, 2013-2020 
Exhibit 3-17: AP & ROW Market Forecast for Transdermal Patches by Application, 2013-2020 
Exhibit 3-18: AP & ROW Market Forecast for Iontophoresis Devices, 2013-2020 
Exhibit 3-19: OUS Supplier Shares, Transdermal Drug Delivery Technologies,  2013 and 2014 
Exhibit 3-20: U.S. Market Forecast for Inhalation Technologies by Type, 2013-2020 
Exhibit 3-21: U.S. Market Forecast for Dry Powder Inhalers, 2013-2020 
Exhibit 3-22: U.S. Market Forecast for Metered Dose Inhalers, 2013-2020 
Exhibit 3-23: U.S. Market Forecast for Nebulizers, 2013-2020 
Exhibit 3-24: U.S. Supplier Shares, Inhalation Technologies, 2013 and 2014 
Exhibit 3-25: European Market Forecast for Inhalation Technologies by Type, 2013-2020 
Exhibit 3-26: European Market Forecast for Dry Powder Inhalers, 2013-2020 
Exhibit 3-27: European Market Forecast for Metered Dose Inhalers, 2013-2020 
Exhibit 3-28: European Market Forecast for Nebulizers, 2013-2020 
Exhibit 3-29: AP & ROW Market Forecast for Inhalation Technologies by Type, 2013-2020 
Exhibit 3-30: AP & ROW Market Forecast for Dry Powder Inhalers, 2013-2020 
Exhibit 3-31: AP & ROW Market Forecast for Metered Dose Inhalers, 2013-2020 
Exhibit 3-32: AP & ROW Market Forecast for Nebulizers, 2013-2020 
Exhibit 3-33: OUS Supplier Shares, Inhalation Technologies, 2013 and 2014 

4. COMPANY PROFILES
 
4.1 3M Health Care 
4.2 Actavis (Allergan) 
4.3 CareFusion 
4.4 DJO Global 
4.5 DeVilbiss Healthcare 
4.6 GlaxoSmithKline 
4.7 Johnson & Johnson 
4.8 Monaghan Medical 
4.9 Mylan 
4.10 Novartis 
4.11 Noven Pharmaceuticals (Hisamitsu Pharmaceutical) 
4.12 Philips Healthcare 
4.13 Salter Labs 
4.14 Smiths Medical 
4.15 Somerset Pharmaceuticals 
4.16 Teikoku Pharma 
4.17 Teleflex Medical 
4.18 UCB

Companies Covered

3M Health Care
Acorda Therapeutics
Actavis (Allergan)
ActivaDerm
ActivaTek
Aerogen
Agile Therapeutics
Aveva
Axelgaard Manufacturing Co.
Baxter
Bayer Healthcare
CareFusion
Catalent
Chiesi Farmaceutici,
Consort Medical
DJO Global
DeVilbiss Healthcare
Dr. Reddy's Laboratories
Dynatronics
Galen
GlaxoSmithKline
Hercon Pharmaceuticals
IBSA Institut Biochimique
Johnson & Johnson
Lavipharm
Mattioli Engineering Corp.
Medquip
Microlab International
Monaghan Medical
Mylan
Novartis
Noven Pharmaceuticals (Hisamitsu Pharmaceutical)
nSpire Health
Par Pharmaceutical
PARI Respiratory Equipment
Pepin Manufacturing
Philips Healthcare
Presspart
ProStrakan
Respiratory Delivery Systems
RICH-MAR
Salter Labs
Smiths Medical
Somerset Pharmaceuticals
Teikoku Pharma
Teleflex Medical
Teva
Thayer Medical
The Medicines Co.
Travanti Medical
Trudell Medical International
UCB
Valeant Pharmaceuticals
Valois
Westmed
WR Medical Electronics Co.